G

Glaukos Corp
D

GKOS

164.830
USD
-0.71
(-0.43%)
Market Closed
Last updated: · Delayed 15 min
Volume
38,082
EPS
-1
Div Yield
-
P/E
-50
Market Cap
9,722,322,336
Overview
Related Instruments
ABT
ABT
D
Abbott Laboratories
104.880
0.180(0.17%)
104.630-0.250(-0.24%)
ALGN
ALGN
D
Align Technology
147.270
-2.110(-1.41%)
147.450+0.180(+0.12%)
BDX
BDX
D
Becton Dickinson and Co
191.550
-2.160(-1.12%)
COO
COO
D
Cooper Companies (The)
57.919
0.519(0.90%)
57.660-0.259(-0.45%)
E
EYE
D
National Vision Holdings
17.430
-0.225(-1.27%)
ISRG
ISRG
D
Intuitive Surgical
426.75
-1.12(-0.26%)
425.74-1.01(-0.24%)
JNJ
JNJ
D
Johnson & Johnson
255.58
2.24(0.88%)
255.39-0.19(-0.07%)
SYK
SYK
D
Stryker Corp
294.69
1.44(0.49%)
293.61-1.08(-0.37%)
More

Title: Glaukos Corp

Sector: Healthcare
Industry: Medical Devices
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.